Literature DB >> 9788751

Expression of vascular endothelial growth factor during the development of cardiac hypertrophy in spontaneously hypertensive rats.

A M McAinsh1, M Geyer, J Fandrey, J C Rüegg, R J Wiesner.   

Abstract

Left ventricular hypertrophy (LVH) is often associated with an impaired maximal coronary blood flow and increases the vulnerability of the heart tissue to ischaemia. In this study, the correlation between coronary blood flow and expression of the vascular endothelial growth factor (VEGF) mRNA was investigated. Using both haemodynamic measurements and analysis of mRNA, we have demonstrated that during development of LVH, in spontaneously hypertensive rats (SHR), an impaired maximal coronary flow at 12 weeks of age is associated with low levels of VEGF mRNA. However, in older SHR (32 weeks) with stabilised hypertrophy and a normal maximal coronary flow response, VEGF mRNA levels are increased 3-fold. These results suggest that the mechanism for the impaired flow, observed in some types of cardiac hypertrophy, might involve an inadequate growth of the coronary vessels due to insufficient activation of the VEGF gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788751     DOI: 10.1023/a:1006887510678

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries.

Authors:  C G Brilla; J S Janicki; K T Weber
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

2.  The effects of long-term pressure-overload and aging on the myocardium.

Authors:  R J Tomanek; J M Hovanec
Journal:  J Mol Cell Cardiol       Date:  1981-05       Impact factor: 5.000

3.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

4.  Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed.

Authors:  R S Cooper; B E Simmons; A Castaner; V Santhanam; J Ghali; M Mar
Journal:  Am J Cardiol       Date:  1990-02-15       Impact factor: 2.778

5.  Cardiac hypertrophy impairs recovery from ischaemia because there is a reduced reactive hyperaemic response.

Authors:  A M McAinsh; M A Turner; D O'Hare; R Nithythyananthan; D G Johnston; D J O'Gorman; D J Sheridan
Journal:  Cardiovasc Res       Date:  1995-07       Impact factor: 10.787

6.  Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis.

Authors:  W M Chilian; R D Wangler; K G Peters; R J Tomanek; M L Marcus
Journal:  Circ Res       Date:  1985-10       Impact factor: 17.367

7.  In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction.

Authors:  J Fandrey; H F Bunn
Journal:  Blood       Date:  1993-02-01       Impact factor: 22.113

8.  Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve.

Authors:  R D Wangler; K G Peters; M L Marcus; R J Tomanek
Journal:  Circ Res       Date:  1982-07       Impact factor: 17.367

9.  Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis.

Authors:  S Banai; D Shweiki; A Pinson; M Chandra; G Lazarovici; E Keshet
Journal:  Cardiovasc Res       Date:  1994-08       Impact factor: 10.787

10.  Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload.

Authors:  Y Chen; R J Torry; G L Baumbach; R J Tomanek
Journal:  Am J Physiol       Date:  1994-12
View more
  1 in total

1.  Maternal nutrient restriction and the fetal left ventricle: decreased angiotensin receptor expression.

Authors:  Jeffrey S Gilbert; Alvin L Lang; Mark J Nijland
Journal:  Reprod Biol Endocrinol       Date:  2005-07-14       Impact factor: 5.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.